Chen, P., Li, Z., & Cai, S. (2023). Case Report: Cadonilimab-related toxic epidermal necrolysis-like reactions successfully treated with supplemental Adalimumab. Frontiers in immunology, 14, 1188523. https://doi.org/10.3389/fimmu.2023.1188523
Chicago Style (17th ed.) CitationChen, Peng-Yu, Zi-Yun Li, and Sui-Qing Cai. "Case Report: Cadonilimab-related Toxic Epidermal Necrolysis-like Reactions Successfully Treated with Supplemental Adalimumab." Frontiers in Immunology 14 (2023): 1188523. https://doi.org/10.3389/fimmu.2023.1188523.
MLA (9th ed.) CitationChen, Peng-Yu, et al. "Case Report: Cadonilimab-related Toxic Epidermal Necrolysis-like Reactions Successfully Treated with Supplemental Adalimumab." Frontiers in Immunology, vol. 14, 2023, p. 1188523, https://doi.org/10.3389/fimmu.2023.1188523.